QCLS - MyMD Pharmaceuticals, Inc.
4.5
1.020 22.667%
Share volume: 10,947,143
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.48
1.02
0.29%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-19-2024 | 11-14-2024 | 05-15-2025 | 08-19-2025 | 11-19-2025 | |
| Cash flow financing | -1.275 M | 14.000 M | 1.202 M | 0.000 | 0.000 | 9.352 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -2.455 M | 310.371 K | 656.325 K | -99.910 K | 0.000 | 6.697 M | |
| Net income | -9.800 M | -9.566 M | -1.929 M | -1.125 M | -1.796 M | -2.811 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 732.024 K | -11.021 M | 3.086 M | 2.540 M | 2.200 M | -1.495 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | -1.134 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -2.455 M | 310.371 K | 656.325 K | -99.910 K | 134.309 K | 6.697 M |